Shopping Cart
Remove All
Your shopping cart is currently empty
Tefibazumab is a humanised monoclonal antibody targeting ClfA (clumping factor A), indicated for the treatment of Staphylococcus aureus bacteraemia.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $247 | - | In Stock | |
| 5 mg | $619 | - | In Stock | |
| 10 mg | $993 | - | In Stock | |
| 25 mg | $1,470 | - | In Stock | |
| 50 mg | $1,980 | - | In Stock |
| Description | Tefibazumab is a humanised monoclonal antibody targeting ClfA (clumping factor A), indicated for the treatment of Staphylococcus aureus bacteraemia. |
| In vitro | Tefibazumab can specifically bind to ClfA expressed by Staphylococcus aureus, and in the amino acid sequence of its variable antigen-binding region, the proportion of human-derived components exceeds 98%, while the proportion of murine-derived components is less than 2% [2]. |
| Synonyms | INH-H2002, INH-H 2002 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Host Species | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Cas No. | 521079-87-8 |
| Color | Transparent |
| Appearance | Liquid |
| Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.